Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
topsalysin (1 trial)
Hyperplasia (Phase 2)
Prostatic Hyperplasia (Phase 2)
Trials (1 total)
Trial APIs (1 total)